Clinical Trials

  LONDON, Aug. 20, 2008--A new drug for cystic fibrosis, PTC124, can bypass the genetic defect in the protein-making machinery of patients and improve the functioning of cell membranes that is normally hampered by the condition. These are the...

CRANBURY, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - VaxInnate Corporation announced today that its M2e universal influenza vaccine candidate was safe and immunogenic in its first Phase I clinical trial, raising hopes for a universal influenza vaccine...

WEIZMANN SCIENCE PARK, NESS ZIONA, Israel--(BUSINESS WIRE)--Aug. 21, 2008 - Kamada (TASE: KMDA), a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced...

GLASGOW, Scotland--(BUSINESS WIRE)--Aug. 21, 2008 - Javelin Pharmaceuticals, Inc. (Amex: JAV), a leading developer of novel products for pain management, today presented new and successful secondary endpoint data from a previously announced pivotal...

CORAL GABLES, Fla., Aug 21, 2008 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. today reported that animal data from a new study sponsored by scientists at the U.S. Department of Energy's Brookhaven National Laboratory appears...

ROCKVILLE, Md., August 21, 2008 /PRNewswire-FirstCall/ -- Novavax, Inc. today announced that the Company will hold an investor conference call to discuss results from the Phase I/IIa human clinical trial of Novavax's H5N1 pandemic influenza VLP...

New analysis of landmark study showed patients taking prasugrel had lower risk of combined endpoint of recurrent heart attack, stroke or cardiovascular death after first event than those taking clopidogrel TOKYO and INDIANAPOLIS, August 21, 2008...

OSLO, Norway, Aug. 21, 2008--A newly published study shows that PDT treatment with MAL (Metvix ®) is effective in preventing new AK lesions in organ transplant patients.    Organ transplant recipients on long-term immunosuppressive...

    SOUTH PLAINFIELD, N.J.August 20, 2008 /PRNewswire/ -- New phase 2 data published today in show that the investigational oral drug PTC124 demonstrates activity in nonsense-mutation cystic fibrosis (CF). The data show that treatment with...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Aug 21, 2008 - Repros Therapeutics Inc. (NasdaqGM:RPRX) today released the evaluation of the microscopic assessment of tissues from a six-month mouse study conducted to satisfy a portion of the FDA mandated...

SAN DIEGO, August 21, 2008 /PRNewswire-FirstCall/ -- Vical Incorporated today announced that results from nonhuman primate studies of a Vaxfectin(R)-formulated DNA vaccine for measles, published in the August issue of Clinical and Vaccine...

BLUE BELL, Pa., August 20, 2008 /PRNewswire/ -- TheraQuest Biosciences, Inc. a development stage pain management company is presenting data today on TQ-1019, its proprietary topical local anesthetic and on SECUREL(R), its abuse deterrent technology...

PHILADELPHIA, August 20, 2008 /PRNewswire/ -- Peer-reviewed safety and efficacy data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)), successfully applied to patients suffering from treatment-resistant chronic pain appeared in...

SYDNEY, Australia, August 20, 2008 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced that the Phase 3 clinical trial evaluating the long term safety of Bronchitol in subjects with bronchiectasis has concluded with no...

  BETHESDA, Md., Aug. 19, 2008--The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID),...

LANSDALE, Pa.--(BUSINESS WIRE)--Aug 19, 2008 - Hayes, Inc., an industry leader in providing independent, unbiased analyses of healthcare technologies, today announced that it has completed an exhaustive study of a wide range of medications to treat...

Results of Phase II and III trials add to growing bank of clinical evidence regarding prolonged release oxycodone / naloxone Cambridge, UK,  August 19, 2008- Prolonged release oxycodone / naloxone is as effective as oxycodone alone in providing...

LANSING, Mich., August 19, 2008 /PRNewswire/ -- Afid Therapeutics, Inc. announced today that it had completed successful in vitro and in vivo (whole animal) demonstrations of the efficacy of its new "traceless" anticoagulant, which is meant to...

TARRYTOWN, N.Y. & LEVERKUSEN, Germany--(BUSINESS WIRE)--Aug 19, 2008 - Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG today announced that patients with wet age-related macular degeneration (AMD) receiving VEGF Trap-Eye...

  ROCKVILLE, Md., Aug. 18, 2008--Elderly patients who are prescribed a conventional, or first-generation, antipsychotic medication are at an increased risk of death from cardiovascular or respiratory diseases as compared to those who take an...